OWC Pharmaceutical Research Corp. (OTCQB: OWCP)

Transcription

1 OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, was featured in the comments of its Advisory Board member, Jeffrey Friedland. In addition to serving on the Company's Advisory Board, Mr. Friedland is the Chief Executive Officer of Intiva Inc., author of Marijuana: The World's Most Misunderstood Plant, and frequent keynote speaker for the cannabis industry. Recently, Mr. Friedland commented on the pending election and the possible effects on the future of the cannabis industry, "Many entrepreneurs and investors have expressed their concerns to me regarding the outcome of Tuesday's U.S. presidential election, specifically whether the winner will have a positive or negative impact on the cannabis industry. Both Hillary Clinton and Donald Trump have stated that they will support the medical use of cannabis." Mr. Friedland went on to say, "Regardless of the outcome of Tuesday's vote, I see no immediate change in the existing system of allowing state-licensed medical cannabis businesses, nor do I see any immediate change in the rescheduling of cannabis under the Controlled Substances Act..What is more significant to the U.S. cannabis industry is Tuesday's outcome of voting in California and Nevada, where adult recreational use of cannabis is on the ballot. I'm expecting voters in both states to approve recreational cannabis." Regarding Intiva's investment in OWC, Mr. Friedland had this to say, "The decision to invest in OWC during the summer of 2014 came after spending some time in Israel, where I concluded that the real money in the cannabis industry will be made by companies who create 'real pharmaceuticals based on real science.' I was impressed with OWC's management team; Dr. Yehuda Baruch, the Company's director of research, was the former head of Israel's medical cannabis program. I also found intriguing the early-stage research OWC had underway regarding trials of their proprietary cannabis-based formulations for the treatment of multiple myeloma and other conditions." As for the potential effect of the election on OWC, Mr. Friedland added that if, as he expected, California and Nevada approved recreational cannabis, the Company had "plenty to gain from Tuesday's vote in the U.S as OWC Pharmaceutical Research recently announced that it has entered into a U.S. license agreement with a Maryland-based company to bring its topical psoriasis cream to state-licensed businesses in the U.S. market.and the establishment of recreational cannabis businesses in California and Nevada would significantly increase the availability of medical cannabis for patients in those states. OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively "OWC" or the "Company") conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.

2 The Company's Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks. North American Cannabis Holdings, Inc. (OTCBB: USMJ) North American Cannabis Holdings, Inc. (USMJ) and Puration, Inc. (PURA) are two cannabis sector companies working closely together to be prepared for the possibility that marijuana legalization proposals could lead to the legal marijuana sector growing from a $7 billion market today into a $22 billion market in four years from now. USMJ has carved out a base annual revenue of $500k since entering the cannabis sector in USMJ also developed and spun off the cannabis extraction business that is now the primary operation of PURA. PURA has recently announced its first two contracts and indicated a third is pending. Together, USMJ and PURA have been coordinating efforts to open an office in California in anticipation of Proposition 64 passing today and making recreational marijuana legal. Marijuana Sector Growth Projections from Recent New York Times Article The market for both recreational and medicinal marijuana is projected to grow to $22 billion in four years from $7 billion this year if California says yes, according to projections by the Arcview Group, a company that links investors with cannabis companies (New York Times). North American Marijuana Index Increases 100 Points and Could Go Higher The North American Marijuana Index (marijuanaindex.com) has increased almost 100 points in the last two months from September 1st at to November 1st at A strong legalization showing tomorrow could see marijuana stocks go much higher on the reality of legalization compared to the hope for legalization. Today's Marijuana Ballot Initiatives and Where Marijuana Is Already Legal Recreational marijuana is legal today in Washington, Oregon, Colorado and Alaska. 25 states all together have some form of legal marijuana as does the District of Columbia. Recreational marijuana legalization is on the ballot in California, Massachusetts, Maine, Arizona and Nevada. Medical marijuana legalization is on the ballot in Arkansas, Florida and North Dakota. International Consolidated Companies, Inc. (OTCBB: INCC) St. James Remedies will be selling its products, a better, smarter delivery system technology for CBD, and licensing its brand to Marijuana Infused Products companies (MIPs) in the states where medical marijuana are state legal. The MIP will add THC to the SJR capsule, making it a salable item in the medical dispensaries. INCC CEO and Chairman Antonio F. Uccello has notified the company that he will direct St. James Remedies (SJR) to issue a portion of the shares due to him to the shareholders of INCC. The companies intend to accomplish this by registering the shares and having them issued as a stock dividend to the INCC shareholders.

3 "We are very excited to be a part of the medical solutions without being directly involved in the addition of THC or direct sales of medical marijuana products." St. James Remedies currently include cannabidiol (CBD) based wellness drinks, and gel caps. According to Uccello, INCC is analyzing additional, innovative acquisitions in the growing cannabis and hemp space. INCC, and a multitude of others that may decided to end prohibition in the November election. "Now that we have a definitive path we will be completing the steps needed to bring INCC in compliance with OTC markets," he said. "As the sale of assets is no longer possible, I want to ensure the INCC shareholders still received a similar distribution." Other announcements include the retention of Proven Media, an award-winning public relations firm for cannabis and hemp companies. "Opportunities abound for an experienced company like IINC and St. James Remedies. We are poised and prepared for aggressive and expansive growth," Uccello said. The company is expected to announce additional expansion plans in November. International Consolidated Companies (INCC) was founded in INCC and its subsidiaries are in the business of people - helping people, through the development of quality hemp products and services, which bring new energy to the world and will ultimately create prosperity for investors. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient technologies. EffTec International, Inc. (OTCBB: EFFI) announce new purchase orders for the first product in a new and exciting full line of breakfast products called HempStart, starting with All Natural Health & Energy Bars. Our initial purchase order is from nine (9) Donut Bank Stores in 3 States along with purchase orders from forty (40) convenience / grocery stores, with many of these being "Large Chain Stores" with locations throughout 5 states all within a 150 mile radius of HempLife 's Midwest base of operations in southern Indiana. The initial reaction from customers has been overwhelming and we hope to capitalize on this growing market immediately. The company is currently developing a full spectrum online store, HempLife Brands, that will describe all the offerings of HempLife Industries including the HempStart line. HempLife Industries will continue to be managed by its founder and innovator, Mr. Anthony Skinner, who has over twenty years of experience and is well-known and respected throughout the industry. HempLife, which was a private Midwest Company, was purchased by Efftec last week in a deal previously announced, and brings a large and impressive portfolio of secured Trademarks and Web Domains. We will enforce all of our intellectual property rights that such Trademarks and Domain Names provide under the law. Efftec International. Inc. is a holding company whose mission is to continue its steady growth and become a market leader through strategic acquisitions and organic growth. The company's core business focus is on sales of hardware and nutrients into the hydroponics and indoor growth markets. DISCLAIMER

4 FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the subject company in this report to be materially different from the statements made herein. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. The subject Companies have not compensated Traders News Source for the creation or dissemination of this report. Traders News Source is the party responsible for issuing this report/release and for hosting the full report on Traders News Source website. NOT FINANCIAL ADVICE Traders News Source makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Traders News Source is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Traders News Source whatsoever for any direct, indirect or consequential loss arising from the use of this document. Traders News Source expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Traders News Source does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. Traders News Source produces reports, articles, blogs, and investment newsletters covering companies listed on NYSE and NASDAQ exchanges. Traders News Source has two distinct and independent operating segments. One produces non-compensated analyst and or expert certified content generally in the form of press releases, articles and reports. The other produces compensated content, which typically consists of compensated investment newsletters, articles and reports.

5 HIGH DEGREE OF RISK There is an extremely high inherent risk when investing in micro and small cap securities that have little to no revenue. You could lose your entire investment. Source: Traders News Source Contact: